EFGCP is organizing an interactive workshop intended to develop practical strategies and approaches for risk management and risk-based monitoring in clinical trials
The European Forum for Good Clinical Practice (EFGCP) is organizing an interactive workshop intended to develop practical strategies and approaches for risk management and risk-based monitoring in clinical trials. The event, to be held on June 16 and 17 at University College London (UCL), UK, is being put together by the EFGCP’s Education Working Party in association with the Alliance for Clinical Research Excellence and Safety (ACRES), European Organization for Research and Treatment of Cancer (EORTC), and UCL.
“Up to now discussions on risk management have been mainly theoretical and the practicalities of ‘how to’ have not been defined. Yet nobody is sure how much is actually ‘enough’ and how much is too little,” stated the organizers. “Research organizations are starting to create their approaches to risk assessment and risk-based monitoring and yet there are still questions which need to be addressed, especially on how to define, justify and ‘validate’ what is critical to patients' safety, integrity and rights, and data integrity.”
The workshop has been developed in collaboration with thought leaders from health authorities, industry, CROs, academia and patients’ representatives, according to EFGCP. At the end of the meeting, a roundtable discussion with regulators is planned to decide whether the approaches developed during the workshop are likely to be acceptable. Those delegates who are more knowledgeable on risk assessment and management will drive during the workshop the discussion based on their ‘hands on’ experience, others that are less familiar with these concepts can adopt a more observational role.
HHS Cancels Moderna Grant for Late-Stage Development of mRNA Vaccine Candidate
June 4th 2025Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s award for almost $600 million to accelerate vaccine development will be terminated.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
America’s Vanishing Scientific Research Workforce is a Threat to Public Health
June 2nd 2025As biotech innovation accelerates, the clinical research workforce is rapidly eroding—threatening the future of drug development. From workforce burnout to training program cuts and talent pipeline collapse, clinical trial professionals must confront this escalating crisis head-on to sustain progress and protect public health.